SEC Filing Summary: Kinsale Capital Group, Inc.
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by Kinsale Capital Group, Inc. The reporting period covers holdings as of December 31, 2025. The document discloses the company's equity securities held in the United States, detailing the number of shares, value, and voting authority for each position.
Key Financial Metrics and Portfolio Composition
The filing provides a snapshot of the company's investment portfolio rather than its operational financials (revenue, profit, or cash flow). Key portfolio metrics include:
- Total Positions Disclosed: 42 distinct equity holdings.
- Largest Holdings by Value:
- Vanguard Index Fds Total Stk Mkt: $109,402,583 (326,312 shares)
- Vanguard Index Fds S&P 500 ETF: $76,120,698 (121,379 shares)
- JPMorgan Chase & Co: $18,288,139 (56,757 shares)
- Walmart Inc: $18,110,416 (162,556 shares)
- Johnson & Johnson: $15,265,354 (73,763 shares)
- Voting Authority: The company reports Sole voting authority for all listed positions. No shared or none voting authority is reported.
- Derivatives: No put or call options are reported in this filing.
Material Changes and Portfolio Strategy
As this is a standalone snapshot of holdings, the filing text does not provide comparative data against the prior quarter to determine material changes in position size or value. However, the portfolio composition indicates a strategy heavily weighted toward:
- Passive Index Exposure: Significant allocation to broad market ETFs (Vanguard Total Stock Market and S&P 500).
- Large-Cap Diversification: Holdings span multiple sectors including Technology (Apple, Microsoft, Oracle), Healthcare (Amgen, J&J, UnitedHealth), Financials (JPMorgan, Charles Schwab), and Consumer Staples (Walmart, McDonald's).
Guidance, Risks, and Contingencies
The filing text does not contain management commentary, forward-looking guidance, or specific risk factors related to the company's operations. It strictly adheres to the regulatory requirement of disclosing beneficial ownership of equity securities. The standard SEC disclaimer notes that the Commission has not reviewed the information for accuracy or completeness.
Investor Verification Checklist
- Verify the total aggregate value of the portfolio by summing the "Value" column to assess total equity exposure.
- Confirm the concentration risk by calculating the percentage of the portfolio held in the two Vanguard ETFs versus individual stock picks.
- Check subsequent filings (e.g., 10-Q or 10-K) for operational financial metrics (revenue, underwriting results) which are not present in this 13F form.
- Review the "Sole" voting authority designation to confirm full control over the disclosed positions.